+1 0 2 0 2 B-lower_bound
or 3 5 3 5 O
more 6 10 6 10 O
vitreous 11 19 11 19 B-clinical_variable
haze 20 24 20 24 I-clinical_variable
( 25 26 25 26 O
according 26 35 26 35 O
to 36 38 36 38 O
Standardization 39 54 39 54 O
of 55 57 55 57 O
Uveitis 58 65 58 65 O
Nomenclature 66 78 66 78 O
( 79 80 79 80 O
SUN 80 83 80 83 O
) 83 84 83 84 O
criteria 85 93 85 93 O
) 93 94 93 94 O

Active 0 6 95 101 O
chorioretinitis 7 22 102 117 B-chronic_disease
or 23 25 118 120 O
leakage 26 33 121 128 O
on 34 36 129 131 O
Fluorescein 37 48 132 143 B-treatment
angiography 49 60 144 155 I-treatment
( 61 62 156 157 I-treatment
FA)(that 62 70 157 165 I-treatment
is 71 73 166 168 O
in 74 76 169 171 O
more 77 81 172 176 O
than 82 86 177 181 O
one 87 90 182 185 B-lower_bound
quadrant 91 99 186 194 I-lower_bound
) 99 100 194 195 O
that 101 105 196 200 O
requires 106 114 201 209 O
treatment 115 124 210 219 B-treatment

Active 0 6 220 226 B-chronic_disease
disease 7 14 227 234 I-chronic_disease
is 15 17 235 237 O
defined 18 25 238 245 O

Both 0 4 246 250 O
female 5 11 251 257 B-gender
participants 12 24 258 270 I-gender
of 25 27 271 273 O
childbearing 28 40 274 286 O
potential 41 50 287 296 O
and 51 54 297 300 O
male 55 59 301 305 O
participants 60 72 306 318 O
able 73 77 319 323 O
to 78 80 324 326 O
father 81 87 327 333 O
a 88 89 334 335 O
child 90 95 336 341 O
must 96 100 342 346 O
have 101 105 347 351 O
( 106 107 352 353 O
or 107 109 353 355 O
have 110 114 356 360 O
a 115 116 361 362 O
partner 117 124 363 370 O
who 125 128 371 374 O
has 129 132 375 378 O
) 132 133 378 379 O
had 134 137 380 383 O
a 138 139 384 385 O
hysterectomy 140 152 386 398 B-treatment
or 153 155 399 401 O
vasectomy 156 165 402 411 B-treatment
, 165 166 411 412 O
be 167 169 413 415 O
completely 170 180 416 426 O
abstinent 181 190 427 436 O
from 191 195 437 441 O
intercourse 196 207 442 453 O
or 208 210 454 456 O
must 211 215 457 461 O
agree 216 221 462 467 B-contraception_consent
to 222 224 468 470 I-contraception_consent
practice 225 233 471 479 I-contraception_consent
two 234 237 480 483 I-contraception_consent
effective 238 247 484 493 I-contraception_consent
methods 248 255 494 501 I-contraception_consent
of 256 258 502 504 I-contraception_consent
contraception 259 272 505 518 I-contraception_consent
throughout 273 283 519 529 O
the 284 287 530 533 O
course 288 294 534 540 O
of 295 297 541 543 O
the 298 301 544 547 O
study 302 307 548 553 O
and 308 311 554 557 O
for 312 315 558 561 O
six 316 319 562 565 O
weeks 320 325 566 571 O
after 326 331 572 577 O
the 332 335 578 581 O
last 336 340 582 586 O
investigational 341 356 587 602 O
product 357 364 603 610 O
injection 365 374 611 620 O

Female 0 6 621 627 B-gender
participants 7 19 628 640 I-gender
of 20 22 641 643 O
childbearing 23 35 644 656 O
potential 36 45 657 666 O
must 46 50 667 671 B-pregnancy
not 51 54 672 675 I-pregnancy
be 55 57 676 678 I-pregnancy
pregnant 58 66 679 687 I-pregnancy

Participant 0 11 688 699 O
has 12 15 700 703 O
a 16 17 704 705 O
known 18 23 706 711 O
hypersensitivity 24 40 712 728 O
to 41 43 729 731 O
ustekinumab 44 55 732 743 B-allergy_name
or 56 58 744 746 O
any 59 62 747 750 O
of 63 65 751 753 O
its 66 69 754 757 O
components 70 80 758 768 O

Participant 0 11 769 780 O
has 12 15 781 784 O
received 16 24 785 793 O
alkylating 25 35 794 804 B-treatment
agents 36 42 805 811 I-treatment
( 43 44 812 813 O
e.g. 44 48 813 817 O
, 48 49 817 818 O
cyclophosphamide 50 66 819 835 B-treatment
, 66 67 835 836 O
chlorambucil 68 80 837 849 B-treatment
) 80 81 849 850 O
within 82 88 851 857 O
the 89 92 858 861 O
last 93 97 862 866 B-upper_bound
nine 98 102 867 871 I-upper_bound
months 103 109 872 878 I-upper_bound

Participant 0 11 879 890 O
has 12 15 891 894 O
received 16 24 895 903 O
intraocular 25 36 904 915 B-treatment
( 37 38 916 917 I-treatment
or 38 40 917 919 I-treatment
periocular 41 51 920 930 I-treatment
) 51 52 930 931 I-treatment
steroi 53 59 932 938 I-treatment

Participant 0 11 939 950 O
is 12 14 951 953 O
18 15 17 954 956 B-lower_bound
years 18 23 957 962 I-lower_bound
of 24 26 963 965 O
age 27 30 966 969 B-age
or 31 33 970 972 O
older 34 39 973 978 O

Participant 0 11 979 990 O
received 12 20 991 999 O
a 21 22 1000 1001 O
live 23 27 1002 1006 B-treatment
vaccination 28 39 1007 1018 I-treatment
within 40 46 1019 1025 O
the 47 50 1026 1029 O
past 51 55 1030 1034 B-upper_bound
six 56 59 1035 1038 I-upper_bound
weeks 60 65 1039 1044 I-upper_bound

have 0 4 1045 1049 O
a 5 6 1050 1051 O
negative 7 15 1052 1060 B-pregnancy
pregnancy 16 25 1061 1070 I-pregnancy
test 26 30 1071 1075 O
at 31 33 1076 1078 O
screening 34 43 1079 1088 O

must 0 4 1089 1093 O
be 5 7 1094 1096 O
willing 8 15 1097 1104 O
to 16 18 1105 1107 O
undergo 19 26 1108 1115 B-pregnancy
pregnancy 27 36 1116 1125 I-pregnancy
testing 37 44 1126 1133 O
throughout 45 55 1134 1144 O
the 56 59 1145 1148 O
study 60 65 1149 1154 O

quantiferon 0 11 1155 1166 O
testing 12 19 1167 1174 O
done 20 24 1175 1179 O
within 25 31 1180 1186 O
three 32 37 1187 1192 B-upper_bound
months 38 44 1193 1199 I-upper_bound
prior 45 50 1200 1205 I-upper_bound
to 51 53 1206 1208 O
enrollment 54 64 1209 1219 O
or 65 67 1220 1222 O
had 68 71 1223 1226 O
latent 72 78 1227 1233 O
tuberculosis 79 91 1234 1246 B-chronic_disease
( 92 93 1247 1248 I-chronic_disease
TB 93 95 1248 1250 I-chronic_disease
) 95 96 1250 1251 I-chronic_disease
but 97 100 1252 1255 O
has 101 104 1256 1259 O
completed 105 114 1260 1269 O
prophylactic 115 127 1270 1282 O
anti 128 132 1283 1287 B-treatment
- 132 133 1287 1288 I-treatment
TB 133 135 1288 1290 I-treatment
treatment 136 145 1291 1300 I-treatment

surgical 0 8 1301 1309 B-treatment
sterilization 9 22 1310 1323 I-treatment
( 23 24 1324 1325 I-treatment
tubal 24 29 1325 1330 I-treatment
ligation 30 38 1331 1339 I-treatment
) 38 39 1339 1340 I-treatment

